نتایج جستجو برای: brca1 و brca2

تعداد نتایج: 770130  

2010
Safinaz S Ibrahim Elsayed E Hafez Mervat M Hashishe

BACKGROUND Breast cancer is one of the most common diseases affecting women. Inherited susceptibility genes, BRCA1 and BRCA2, are considered in breast, ovarian and other common cancers etiology. BRCA1 and BRCA2 genes have been identified that confer a high degree of breast cancer risk. OBJECTIVE Our study was performed to identify germline mutations in some exons of BRCA1 and BRCA2 genes for ...

2012
Farid Cherbal Nadjet Salhi Rabah Bakour Saida Adane Kada Boualga Philippe Maillet

BACKGROUND BRCA1 and BRCA2 germline mutations predispose heterozygous carriers to hereditary breast/ovarian cancer. However, unclassified variants (UVs) (variants with unknown clinical significance) and missense polymorphisms in BRCA1 and BRCA2 genes pose a problem in genetic counseling, as their impact on risk of breast and ovarian cancer is still unclear. The objective of our study was to ide...

2015
Yosuke Hirotsu Hiroshi Nakagomi Ikuko Sakamoto Kenji Amemiya Hitoshi Mochizuki Masao Omata

Tumor suppressor genes BRCA1 and BRCA2 are the two main breast and ovarian cancer susceptibility genes, and their genetic testing has been used to evaluate the risk of hereditary breast and ovarian cancer (HBOC). While several studies have reported the prevalence of BRCA1 and BRCA2 mutations in Japanese populations, there is insufficient information about deleterious mutations compared with wes...

Journal: :Journal of medical genetics 2005
A M Woodward T A Davis A G S Silva J A Kirk J A Leary

INTRODUCTION A strong family history of breast and/or ovarian cancer can often be explained by small insertions, deletions, or substitutions in BRCA1 or BRCA2 and large genomic rearrangements in BRCA1. However, there is little evidence that genomic rearrangements are a major factor in BRCA2 associated breast cancer and the frequencies of rearrangements in BRCA1 in large clinic based populations...

Journal: :Human molecular genetics 2012
Clare Turnbull Sheila Seal Anthony Renwick Margaret Warren-Perry Deborah Hughes Anna Elliott David Pernet Susan Peock Julian W Adlard Julian Barwell Jonathan Berg Angela F Brady Carole Brewer Glen Brice Cyril Chapman Jackie Cook Rosemarie Davidson Alan Donaldson Fiona Douglas Lynn Greenhalgh Alex Henderson Louise Izatt Ajith Kumar Fiona Lalloo Zosia Miedzybrodzka Patrick J Morrison Joan Paterson Mary Porteous Mark T Rogers Susan Shanley Lisa Walker Munaza Ahmed Diana Eccles D Gareth Evans Peter Donnelly Douglas F Easton Michael R Stratton Nazneen Rahman

There have been few definitive examples of gene-gene interactions in humans. Through mutational analyses in 7325 individuals, we report four interactions (defined as departures from a multiplicative model) between mutations in the breast cancer susceptibility genes ATM and CHEK2 with BRCA1 and BRCA2 (case-only interaction between ATM and BRCA1/BRCA2 combined, P = 5.9 × 10(-4); ATM and BRCA1, P=...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2009
Shirley M H Sy Michael S Y Huen Junjie Chen

Mutations in breast cancer susceptibility gene 1 and 2 (BRCA1 and BRCA2) predispose individuals to breast and ovarian cancer development. We previously reported an in vivo interaction between BRCA1 and BRCA2. However, the biological significance of their association is thus far undefined. Here, we report that PALB2, the partner and localizer of BRCA2, binds directly to BRCA1, and serves as the ...

2016
P. Wojcik M. Jasiowka E. Strycharz M. Sobol D. Hodorowicz-Zaniewska P. Skotnicki T. Byrski P. Blecharz E. Marczyk I. Cedrych J. Jakubowicz J. Lubiński V. Sopik S. Narod P. Pierzchalski

BACKGROUND Mutations in the BRCA1, BRCA2 and PALB2 genes are well-established risk factors for the development of breast and/or ovarian cancer. The frequency and spectrum of mutations in these genes has not yet been examined in the population of Southern Poland. METHODS We examined the entire coding sequences of the BRCA1 and BRCA2 genes and genotyped a recurrent mutation of the PALB2 gene (c...

2014
Jong-Han Yu Jong Won Lee Byung Ho Son Sung-Won Kim Sue K. Park Min Hyuk Lee Lee Su Kim Woo-Chul Noh Eun-Kyu Kim Dae Sung Yoon Jeeyeon Lee Jin Hyang Jung Sang Seol Jung Gyungyup Gong Sei-Hyun Ahn

PURPOSE Mutations in BRCA genes are the main cause of hereditary breast cancer in Korea. The aim of this study was to investigate the characteristics of breast cancers involving BRCA1 (BRCA1 group) and BRCA2 (BRCA2 group) mutations. METHODS We retrospectively reviewed the medical records of patients with BRCA1 (BRCA1 group) or BRCA2 (BRCA2 group) mutation positive breast cancer from multiple ...

2011
Ralph Scully

In modern molecular genetics, epistasis analysis is a tool for probing the relationship between two genes and, hence, between the two genes’ products. In its broadest sense, an epistatic relationship exists when combinations of specific alleles of two or more genes generate a quantitative phenotype that differs from the simple addition of phenotypes associated with each individual allele. Many ...

Journal: :JAMA 2011
Da Yang Sofia Khan Yan Sun Kenneth Hess Ilya Shmulevich Anil K Sood Wei Zhang

CONTEXT Attempts to determine the clinical significance of BRCA1/2 mutations in ovarian cancer have produced conflicting results. OBJECTIVE To determine the relationships between BRCA1/2 deficiency (ie, mutation and promoter hypermethylation) and overall survival (OS), progression-free survival (PFS), chemotherapy response, and whole-exome mutation rate in ovarian cancer. DESIGN, SETTING, A...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید